Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 VENITI Closes on $25 Million from Boston Scientific - Medical Product Outsourcing
Financial & Business, OEM News

VENITI Closes on $25 Million from Boston Scientific

Series D funds support stent technology for deep venous therapy.

VENITI Inc., a company involved in the advancement of treatment for deep venous disease, has closed on $25 million in Series D equity financing from Boston Scientific Corporation. The funds will allow VENITI to complete the VIRTUS Trial and regulatory filing for the VICI VENOUS STENT System. The trial is being performed under a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE). The company also intends to expand product development and commercial operations.
 
“We are extremely pleased to be partnering with such a high quality industry leader to advance our core technology, the VICI VENOUS STENT,” said Jeff Elkins, president and CEO of VENITI. “This financing will allow us to complete a number of critical milestones and support more physicians treating patients suffering from venous outflow obstruction around the world.”
 
Venous disease affects millions of people worldwide and is marked by symptoms that include progressive leg pain and swelling, leg heaviness and skin changes. Physicians may choose to treat the obstructive component of venous disease through minimally invasive endovascular stenting procedures. The VICI VENOUS STENT System was designed from inception to meet the unique challenges of the venous system, providing physicians with a balance of crush resistance, flexibility and ease of deployment.
 
Citigroup Global Markets Inc. acted as exclusive financial advisor to VENITI in connection with the transaction.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters